Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease

Ann Intern Med. 2014 Jan 21;160(2):142-3. doi: 10.7326/L14-5001-6.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Benzazepines / economics*
  • Benzazepines / therapeutic use*
  • Female
  • Humans
  • Male
  • Polycystic Kidney, Autosomal Dominant / drug therapy*

Substances

  • Benzazepines